FAQs for ELISA Coating
Coating is the fundamental core step of ELISA experiments. Essentially, it immobilizes specific antibodies or antigens onto the surface of a solid‑phase carrier to build an exclusive antigen‑antibody reaction platform. The quality of coating directly determines the sensitivity, specificity and reproducibility of the whole assay. Many abnormal ELISA results originate from improper coating operations. This FAQ document sorts out principles of coating, key influencing factors, blocking procedures, and the differences between in‑house coated plates and commercial pre‑coated kits, to help researchers troubleshoot common coating‑related experimental problems.
Q1: What core functions does coating perform in ELISA?
A: Coating achieves three major functions.
1. Guarantee reaction specificity: By immobilizing specific antigens or antibodies, only matched molecules in samples can bind in subsequent steps, which reduces non‑specific adsorption and avoids false‑positive results.
2. Improve detection sensitivity: Optimized coating enables uniform and sufficient immobilization of target molecules on the solid‑phase surface, maximizing capture of analytes in samples. Even analytes at extremely low concentrations can be detected through downstream enzymatic reactions.
3. Maintain experimental stability: Standardized coating ensures consistent immobilized target quantity across different plates and wells, minimizing intra‑batch and inter‑batch variations.
1. Guarantee reaction specificity: By immobilizing specific antigens or antibodies, only matched molecules in samples can bind in subsequent steps, which reduces non‑specific adsorption and avoids false‑positive results.
2. Improve detection sensitivity: Optimized coating enables uniform and sufficient immobilization of target molecules on the solid‑phase surface, maximizing capture of analytes in samples. Even analytes at extremely low concentrations can be detected through downstream enzymatic reactions.
3. Maintain experimental stability: Standardized coating ensures consistent immobilized target quantity across different plates and wells, minimizing intra‑batch and inter‑batch variations.
Q2: What substances should be selected for ELISA coating?
A: Coating materials depend on detection targets. Use specific antibodies for antigen detection; use corresponding antigens for antibody detection. For small‑molecule analytes such as hormones and drugs, small molecules cannot be efficiently adsorbed onto solid‑phase surfaces directly. They must be conjugated with carrier proteins prior to coating.
Q3: How to select coating buffer and pH value? What happens if pH deviates from optimal range?
A: Two commonly‑used buffers are carbonate buffer (pH 9.0‑9.6) and phosphate buffer (pH 7.2‑7.4). They promote protein adsorption on microplate wells via electrostatic interactions. Deviation from optimal pH will reduce coating efficiency. For instance, excessively low pH makes proteins positively‑charged and weakens protein‑plate adsorption, leading to insufficient coated protein.
Q4: How to set coating protein concentration and incubation conditions? Is post‑incubation treatment required?
A: Regular protein coating concentration ranges from 1‑10 μg/mL. For small‑molecule antigens with low molecular weight and limited binding sites, higher concentration (5‑20 μg/mL) is recommended. Two incubation protocols are available: overnight incubation at 4 ℃ or 2‑hour incubation at 37 ℃.
After incubation, wash the plate 3 times with PBST containing 0.05% Tween‑20 to remove unbound coating materials and prevent interference with subsequent reactions.
After incubation, wash the plate 3 times with PBST containing 0.05% Tween‑20 to remove unbound coating materials and prevent interference with subsequent reactions.
Q5: Why is blocking indispensable after coating? What problems will incomplete blocking cause?
A: After coating, plenty of vacant sites remain on well surfaces. Without blocking, enzyme‑linked secondary antibodies or miscellaneous sample proteins will bind non‑specifically to these sites. 5% non‑fat milk or 1% BSA are typical blocking solutions. Incomplete blocking leads to elevated blank‑well signals and higher CV values, which is a frequently‑overlooked point for in‑house coated plates.
Q6: What are the technical challenges of uncoated‑type ELISA kits?
A: ① Cumbersome preparation: Researchers need to prepare coating buffer and blocking solution by themselves, and perform pre‑experiments to optimize coating concentration. ② Manual coating (4 ℃ overnight or 37 ℃ for 2 h) and blocking (37 ℃ for 1 h) are required. The whole procedure takes 12‑24 hours before sample loading. ③ Strict operation requirements. Minor variations in coating concentration, incubation temperature or time will introduce experimental errors. Novices often obtain poor‑reproducibility data.
Q7: What are the advantages of pre‑coated ELISA kits compared with self‑coated plates?
A: ① No coating‑step optimization required. Users can run detection directly following manuals, saving considerable experimental time. ② Standardized manufacturing delivers excellent reproducibility, high sensitivity and strong specificity to guarantee reliable results. ③ Stable performance supports continuous detection of large‑volume samples. ④ Validated with routine samples to provide experimental references for researchers. ⑤ Fast delivery and comprehensive professional technical support.
Q8: When should I choose pre‑coated kits versus self‑coated microplates?
A: Pre‑coated commercial kits are preferred for routine sample detection to reduce manual errors and shorten assay cycles. Self‑coated plates are suitable for developing brand‑new ELISA assays for novel targets, when abundant condition‑screening experiments are needed.
Q9: What are common coating‑related abnormal phenomena and their possible causes?
A: ① Low overall signal: Too‑low coating concentration; insufficient incubation time; improper buffer pH reducing protein adsorption; inactivation of coating protein.
② High background and false‑positive results: Insufficient plate‑washing after coating; missing or incomplete blocking.
③ High well‑to‑well CV value: Unequal liquid volume during coating; uneven incubation temperature; incomplete blocking.
② High background and false‑positive results: Insufficient plate‑washing after coating; missing or incomplete blocking.
③ High well‑to‑well CV value: Unequal liquid volume during coating; uneven incubation temperature; incomplete blocking.
Q10: How to choose between overnight 4 ℃ coating and 2‑hour 37 ℃ coating?
A: Overnight incubation at 4 ℃ delivers more uniform protein adsorption, better native protein activity and superior reproducibility, recommended for most proteins, despite longer time‑cost. 2‑hour incubation at 37 ℃ shortens experimental timeline for time‑limited tasks. Note that high temperature may denature certain proteins; thermal stability of target protein should be evaluated in advance.